Loomis, Sayles & Company
EGRX

Loomis, Sayles & Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Loomis, Sayles & Company’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27
Closed -$1K – 1141
2016
Q1 		$1K Buy
+27
New +$1K ﹤0.01% 1028